참고문헌 (19)

1. Ministry of Health and Welfare, Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Kroea in 2019. Sejong: Ministry of Health and Welfare; 2019, p. 1-52. 

2. National Comprehensive Cancer Network. Cervical Cancer; 2022, p. 1-90. 

3. Tewari KS, Sill MW, Long HJ, Penson RT, Huang H, Ramondetta LM, et al. Improved Survival with Bevacizumab in Advanced Cervical Cancer. N Engl J Med 2014 February 20; 370(8):734-43. 

   상세보기

4. Hsiao YH, Lin CW, Wang PH, Hsin MC, Yang SF. The Potential of Chinese Herbal Medicines in the Treatment of Cervical Cancer. Integr Cancer Ther 2019;18:1534735419861693. 

5. Oh SY, Kim MS, Joo JC, Song YS. Efficacy of Herbal medicine as an Adjunctive Therapy of Chemotherapy for Cervical Cancer: A Systematic Review and Meta-analysis. J Physiol & Pathol Korean Med 2020;34(5):255-62. 

   원문보기 상세보기

6. Campos LS, Limberger LF, Stein AT, Caldas JM. Survival after Laparoscopic versus Abdominal Radical Hysterectomy in Early Cervical Cancer: A Randomized Controlled Trial. Asian Pac J Cancer Prev 2021;22(1):93-7. 

   상세보기

7. Kim SI, Lee JW, Hong JY, Lee SJ, Park DC, Yoon JH. Comparison of abdominal and minimally invasive radical hysterectomy in patients with early stage cervical cancer. Int J Med Sci 2021; 18(5):1312-17. 

8. Foucher T, Hennebert C, Dabi Y, Ouldamer L, Lavoue V, Dion L. Recurrence Pattern of Cervical Cancer Based on the Platinum Sensitivity Concept: A Multi-Institutional Study from the FRANCOGYN Group. J Clin Med 2020 Nov 12;9(11):3646. 

   상세보기

9. Tewari KS, Sill MW, Penson RT, Huang H, Ramondetta LM, LM Landrum, et al. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). The Lancet 2017;390(10103) :1654-63. 

10. Lee NH, Yoon DH, Yoo HS, Cho JH, Son CG, Lee YW, et al. Changes of Serum VEGF, bFGF levels and platelet counts in 100 Cancer Patients treated with Hang-Am-Dan. Korean J Orient Int Med 2005;26(4):753-60. 

    원문보기 상세보기

11. Choi WC, Jung HS, Kim KS, Lee SK, Yoon SW, Park JH, et al. Rhus verniciflua Stokes against Advanced Cancer:A Perspective from the Korean Integrative Cancer Center. J Biomed Biotechonol 2012;2012:874276. 

12. Schoen-Angerer T, Wilkens J, Kienle GS, Kiene H, Vagedes J. High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case series. PermJ 2015 Fall;19(4):76-83. 

13. Majeed M, Hakeen KR, Rehman RU. Mistletoe lectins: From interconnecting proteins to potential tumour inhibiting agents. Phytomedicine Plus 2021;1(3):100039. 

    상세보기

14. Grossarth-Maricek R, Ziegler R. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador). Eur J Med Res 2008 Mar 31;13(3):107-20. 

    상세보기

15. Son MK, Jung KH, Lee HS, Lee HS, Kim SJ. SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells. Oncol Rep 2013 Aug;30(2):801-8. 

16. Hong SW, Jung KH, Lee HS, Son MK, Yan HH, Kang NS, et al. SB365, Pulsatilla saponin D, targets c-Met and exerts antiangiogenic and antitumor activities. Carcinogenesis 2013 Sep;34(9):2156-69. 

    상세보기

17. Staff NP, Grisold A, Gristold W, Windebank AJ. Chemotherapy-Induced Peripheral Neuropathy: A Current Review. Ann Neurol 2017 June; 81(6):772-81. 

    상세보기

18. Hu LY, Mi WL, Wu GC, Wang YQ, Mao-Ying QL. Prevention and Treatment for Chemotherapy -Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms. Curr Neuropharmacol 2019;17(2):184-96. 

19. Kim EH, Yoon JH, Lee JY, Yoon SW. The Therapeutic Efficacy of Acupuncture for Chemotherapy-Induced Peripheral Neuropahty: A Systematic Review and Meta-Analysis. J Int Korean Med 2020;41(3):350-61. 

저자의 다른 논문 :

박지혜 (20)